Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
29,557,283
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
323,866
-
Shares change
-
-138,166
-
Total reported value, excl. options
-
$376,141
-
Value change
-
-$190,393
-
Number of buys
-
5
-
Number of sells
-
-7
-
Price
-
$1.15
Significant Holders of BIOTRICITY INC. - Common Stock, par value $0.001 per share (BTCY) as of Q4 2023
22 filings reported holding BTCY - BIOTRICITY INC. - Common Stock, par value $0.001 per share as of Q4 2023.
BIOTRICITY INC. - Common Stock, par value $0.001 per share (BTCY) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 323,866 shares
of 29,557,283 outstanding shares and own 1.1% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (102,576 shares), GEODE CAPITAL MANAGEMENT, LLC (64,074 shares), Strengthening Families & Communities, LLC (48,263 shares), STATE STREET CORP (22,548 shares), CITADEL ADVISORS LLC (21,637 shares), HRT FINANCIAL LP (18,753 shares), BlackRock Inc. (13,375 shares), NORTHERN TRUST CORP (12,002 shares), TD Waterhouse Canada Inc. (8,000 shares), and Tower Research Capital LLC (TRC) (5,647 shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.